ScoreWhy is Kwality Pharmaceuticals Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.04 times
2
With a growth in Net Profit of 74.79%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 9 consecutive quarters
- ROCE(HY) Highest at 21.92%
- INVENTORY TURNOVER RATIO(HY) Highest at 6.43 times
- OPERATING PROFIT TO INTEREST(Q) Highest at 13.41 times
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 07-May-26 and has generated 29.87% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST, DOW and OBV
4
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 2.32% over the previous quarter and collectively hold 3.15% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Kwality Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kwality Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Kwality Pharma
176.42%
2.31
58.59%
Sensex
-1.65%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.48%
EBIT Growth (5y)
-11.57%
EBIT to Interest (avg)
16.48
Debt to EBITDA (avg)
1.14
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
0.98
Tax Ratio
24.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.69%
ROCE (avg)
17.72%
ROE (avg)
77.82%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
37
Price to Book Value
9.80
EV to EBIT
29.34
EV to EBITDA
24.99
EV to Capital Employed
7.36
EV to Sales
6.09
PEG Ratio
0.45
Dividend Yield
NA
ROCE (Latest)
21.47%
ROE (Latest)
20.49%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
